← All trials
NCT03136029
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2018
- Primary completion
- May 1, 2021
- Completion date
- Mar 1, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 140
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Department of Veteran AffairsLead sponsor
- University of UtahCollaborator
- Department of Veteran AffairsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.